These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 18581896

  • 1. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice].
    Zhai ZF, Zhou CL, Zhong BY, Ao JH, Hao F.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):406-10. PubMed ID: 18581896
    [Abstract] [Full Text] [Related]

  • 2. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 05; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):270-9. PubMed ID: 16413531
    [Abstract] [Full Text] [Related]

  • 4. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb 15; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 5. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
    Hu N, Long H, Zhao M, Yin H, Lu Q.
    Scand J Rheumatol; 2009 Feb 15; 38(6):464-71. PubMed ID: 19922023
    [Abstract] [Full Text] [Related]

  • 6. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S.
    Mol Immunol; 2013 Dec 15; 56(4):574-82. PubMed ID: 23911415
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun 15; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

  • 9. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F, Fan MW, Xu QA, Jia R, Guo JH, Bian Z, Chen Z, Peng B, Fan B.
    Zhonghua Yi Xue Za Zhi; 2004 May 02; 84(9):754-9. PubMed ID: 15200917
    [Abstract] [Full Text] [Related]

  • 10. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 02; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 11. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
    Rodgers KE.
    J Autoimmun; 1997 Aug 02; 10(4):367-73. PubMed ID: 9237800
    [Abstract] [Full Text] [Related]

  • 12. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.
    Choi JY, Gao W, Odegard J, Shiah HS, Kashgarian M, McNiff JM, Baker DC, Cheng YC, Craft J.
    Arthritis Rheum; 2006 Oct 02; 54(10):3277-83. PubMed ID: 17009262
    [Abstract] [Full Text] [Related]

  • 13. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
    Tchorbanov AI, Voynova EN, Mihaylova NM, Todorov TA, Nikolova M, Yomtova VM, Chiang BL, Vassilev TL.
    Eur J Immunol; 2007 Dec 02; 37(12):3587-96. PubMed ID: 18034421
    [Abstract] [Full Text] [Related]

  • 14. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Rubio A, Guerrero JM, Osuna C.
    J Pineal Res; 2008 Sep 02; 45(2):204-11. PubMed ID: 18507713
    [Abstract] [Full Text] [Related]

  • 15. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P.
    J Immunol; 2009 Nov 15; 183(10):6207-16. PubMed ID: 19841185
    [Abstract] [Full Text] [Related]

  • 16. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 May 15; 16(5):1326-38. PubMed ID: 15772251
    [Abstract] [Full Text] [Related]

  • 17. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb 15; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 18. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice.
    Schaefer CJ, Wooley PH.
    J Rheumatol; 1999 Oct 15; 26(10):2215-21. PubMed ID: 10529143
    [Abstract] [Full Text] [Related]

  • 19. Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice.
    Hong Y, Wang T, Huang C, Cheng W, Lin B.
    Lupus; 2008 Sep 15; 17(9):814-21. PubMed ID: 18755863
    [Abstract] [Full Text] [Related]

  • 20. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
    Huang XG, Xu JQ, Ren L, Qiu C, Zhang N, Liu LX, Wan YM, Peng H, Shao YM.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 28; 86(44):3109-13. PubMed ID: 17313761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.